The Business of Making a Baby
By Lindsey J. Smith,
San Francisco Magazine [cites CGS' Marcy Darnovsky]
| 03. 23. 2018
After spending her 20s as an aid worker in Africa and India, Helena moved to the Bay Area in 2012, when she was 31. She wanted to apply her public health background to the startup world, so she worked for one health-tech company and then another. She quickly adjusted to life in the city and formed a group of single female friends whose ambitions closely matched her own. To Helena, these young women epitomized the freedom and boundless potential of Silicon Valley: They had worked hard, mapped out paths to promotions, and risen in their fields. They lived as mistresses of their own destinies.
But as their early 30s melted into their mid-30s, a question loomed like storm clouds on the horizon: How and when would any of them have children? Helena (who asked that her last name not be used) and her friends began discussing the option of egg freezing. A consensus soon formed: It was insurance for your future. It let you take your time and find the perfect partner. It would buy you more years to advance...
Related Articles
By Maggie Astor, The New York Times | 06.23.2026
Every year, patients undergo millions of in vitro fertilization procedures worldwide. Only a minority result in a live birth.
In an effort to improve the odds, scientists have developed an array of “add-ons” that could in theory identify the most...
By Carl Zimmer and Catrin Einhorn, The New York Times | 06.25.2026
The Trump administration and a company that is promising to bring long-gone animals back from extinction announced a partnership on Thursday to preserve cells, tissue and DNA from threatened and endangered species.
The company, Colossal Biosciences, said its goal was...
By Marisa Flook , BioNews | 06.29.2026
An anti-ageing gene therapy not approved by the US Food and Drug Administration (FDA) is set to be offered by an American company at overseas clinics outside of US jurisdiction.
The treatment, developed by Minicircle from Austin, Texas, uses a...
By Philip Ball , Nature | 06.17.2026
Our genomes are full of mutations that have the potential to damage our health or even kill us. Yet most of them rarely cause problems. Why? It’s partly thanks to a family of proteins that mask, or ‘buffer’, the ill...